home / stock / csbr / csbr quote
Last: | $4.86 |
---|---|
Change Percent: | -1.65% |
Open: | $4.93 |
Close: | $4.86 |
High: | $5 |
Low: | $4.86 |
Volume: | 1,048 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.86 | $4.93 | $4.86 | $5 | $4.86 | 1,048 | 05-01-2024 |
$4.85 | $4.85 | $4.85 | $4.85 | $4.85 | 826 | 04-30-2024 |
$4.92 | $4.9 | $4.92 | $5 | $4.74 | 4,629 | 04-29-2024 |
$5.02 | $5.03 | $5.02 | $5.03 | $5.02 | 1,620 | 04-26-2024 |
$5.06 | $5.1385 | $5.06 | $5.1385 | $5.06 | 1,477 | 04-25-2024 |
$5.03 | $5.03 | $5.03 | $5.03 | $5.03 | 1,377 | 04-24-2024 |
$5.07 | $5.03 | $5.07 | $5.07 | $5.03 | 2,321 | 04-23-2024 |
$5.06 | $0 | $5.06 | $0 | $0 | 286 | 04-22-2024 |
$5.06 | $5.1 | $5.06 | $5.1 | $5.06 | 960 | 04-19-2024 |
$5.065 | $5.0999 | $5.065 | $5.0999 | $5.065 | 1,206 | 04-18-2024 |
$5.03 | $5.19 | $5.03 | $5.19 | $5.03 | 4,183 | 04-17-2024 |
$5.225 | $5.225 | $5.225 | $5.225 | $5.225 | 398 | 04-16-2024 |
$5 | $0 | $5 | $0 | $0 | 193 | 04-15-2024 |
$5 | $4.8801 | $5 | $5.3 | $4.8801 | 13,368 | 04-12-2024 |
$4.9232 | $4.9232 | $4.9232 | $4.9232 | $4.9232 | 517 | 04-11-2024 |
$4.94 | $4.95 | $4.94 | $4.95 | $4.93 | 1,890 | 04-10-2024 |
$4.98 | $0 | $4.98 | $0 | $0 | 726 | 04-09-2024 |
$4.98 | $4.765 | $4.98 | $5 | $4.765 | 7,405 | 04-08-2024 |
$4.86 | $4.9999 | $4.86 | $4.9999 | $4.86 | 826 | 04-05-2024 |
$4.97 | $4.9 | $4.97 | $4.97 | $4.8318 | 1,683 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Champions Oncology Inc. Company Name:
CSBR Stock Symbol:
NASDAQ Market:
Champions Oncology Inc. Website:
HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024. Thi...
HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced that the College of American Pathologists (CAP) has awarded accreditation to its US-based labora...
HACKENSACK, NJ / ACCESSWIRE / March 6, 2024 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the third quarter ended January 31, 2024, on Tuesday, March...